Hospital system launches nation’s first fully mobile low-dose CT lung cancer screening program

mobile LDCT screening
Clay Marsh, MD, VP of health sciences and executive dean of the school of medicine, Hannah Hazard-Jenkins, MD, WVU Cancer Institute director, Albert Wright Jr., WVU Medicine president and CEO, Kyle Chapman, MD, WVU Medicine pulmonologist

Source

WVU Medicine

West Virginia University Medicine hopes its new LDCT pilot can serve as the model for a nationwide mobile screening rollout.